The pharmaceutical manufacturer Novartis AG has added DDB Worldwide to its roster following a review of its $350 million global ad business.
DDB has been selected to work with its Omnicom sibling, the healthcare specialist Cline Davis & Mann.
As part of the review, Novartis has also reappointed the New York outfit Deutsch, which handles below-the-line ads for the Zelnorm and Lamisil brands.
Join a growing community of media, marketing and advertising professionals today
Read exclusive registrant only articles
Read more articles each month
Sign up for free specialised news bulletins
Register NowGet the very latest news and insight from Campaign with unrestricted access to campaignlive.co.uk, plus get exclusive discounts to Campaign events.
Become a memberOur new premium service offering bespoke monitoring reports for your company.
Find out moreGet the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.
Create an alert now
